Tissue culture studies of demyelinating disease: a critical review

Annals of Neurology
F J Seil

Abstract

Tissue culture studies of human and experimental demyelinating diseases have demonstrated that sera from patients with multiple sclerosis reversibly demyelinate central nervous system cultures. Similar changes are evoked by sera from animals with experimental allergic encephalomyelitis induced by inoculation with whole central nervous system tissue but not by encephalitogenic myelin basic protein. Sera and buffy coat or lymph node cells from humans with idiopathic polyneuritis and animals with experimental allergic neuritis demyelinate cultures of peripheral nervous system tissue. While these studies have contributed to speculations about pathogenetic mechanisms of demyelinating diseases, including the role of both circulating antibodies and delayed hypersensitivity factors, a number of important questions remain unanswered. Among these are the identity of the antigens that evoke antimyelin antibodies and the precise relationship of serum or cellular antimyelin factors to the pathogenesis or clinical course of the demyelinating diseases. Further studies with this technique may provide more complete information about the role of immunological events in induction of disease.

References

Jun 1, 1976·Archives of Neurology·F J SeilJ M Kelly
Apr 1, 1976·Environmental Research·I PetersénJ Persson
Jun 1, 1976·Neurology·F Wolfgram, P Duquette
Jul 1, 1976·Journal of Neurology, Neurosurgery, and Psychiatry·C L SchaufR L Kesler
Aug 11, 1975·Acta Neuropathologica·J LivesonM B Bornstein
Aug 1, 1975·Experimental Neurology·A L LeimanJ M Kelly
Apr 1, 1971·Journal of Neuropathology and Experimental Neurology·A HiranoM R Murray
Nov 1, 1974·Journal of Neurochemistry·S W BrostoffH Wisniewski
Sep 1, 1973·Experimental Neurology·A L Leiman, F J Seil
Apr 1, 1974·Archives of Neurology·M S HorwichP B Chauvin
Oct 1, 1973·Journal of the Neurological Sciences·C S RaineM B Bornstein
Oct 1, 1968·Proceedings of the National Academy of Sciences of the United States of America·E H Eylar, G A Hashim
May 21, 1971·Brain Research·C E Lumsden
May 1, 1971·Journal of the Neurological Sciences·M Dubois-DalcqF Gorce
Jan 1, 1965·Acta Neurologica Scandinavica. Supplementum·O Berg, B Källén
Jul 1, 1970·Journal of Neuropathology and Experimental Neurology·S U KimJ A Parker
Apr 1, 1970·Journal of Neuropathology and Experimental Neurology·C S Raine, M B Bornstein
Feb 1, 1971·Archives of Neurology·S D CookJ N Whitaker
Sep 1, 1969·Archives of Neurology·H WiśniewskiP C Dowling
Dec 1, 1965·The Journal of Experimental Medicine·J R David, P Y Paterson
Dec 11, 1965·British Medical Journal·E J Field, D Hughes
Jan 1, 1966·Acta Neurologica Scandinavica·O Heiskanen
Mar 1, 1967·Journal of Neurochemistry·J S O'BrienM B Stern
Jan 1, 1962·Acta Pathologica Et Microbiologica Scandinavica·O BERG, B KALLEN
Jan 1, 1963·Acta Pathologica Et Microbiologica Scandinavica·O BERG, B KALLEN

❮ Previous
Next ❯

Citations

Dec 15, 1993·Journal of Neuroscience Research·L M NotterpekL H Rome
Jan 1, 1989·Acta Neuropathologica·F RihsC Meier
Dec 1, 1984·Italian Journal of Neurological Sciences·V Vella
Sep 1, 1983·Italian Journal of Neurological Sciences·R P LisakA J Summer
Dec 1, 1994·Journal of the Neurological Sciences·L H van den BergS H Notermans
Oct 1, 1989·Journal of Neuroimmunology·H J Schluesener, R Meyermann
Jul 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·C LubetzkiB Zalc
May 9, 2012·Brain : a Journal of Neurology·Christina ElliottChristopher Linington
Aug 1, 1982·The Journal of Clinical Investigation·N CashmanM A Bach
Aug 13, 2015·Multiple Sclerosis and Related Disorders·Peter O Behan, Abhijit Chaudhuri
Dec 1, 1979·Neurochemical Research·J Y WuC C Duncan
Jan 1, 1989·Autoimmunity·N ScoldingA Compston
Jan 1, 1984·Annals of the New York Academy of Sciences·R P LisakD H Silberberg
Aug 23, 2006·Autoimmunity·Horea RusFlorin Niculescu
Jan 29, 2013·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Lorenz C HundgeburthStefanie Kuerten
May 27, 2017·Multiple Sclerosis : Clinical and Laboratory Research·John W Prineas, John D E Parratt
Apr 1, 1982·Scottish Medical Journal·J A Simpson
Oct 1, 1990·Clinical and Experimental Immunology·S J OwenA N Davison
Nov 17, 2020·Frontiers in Neurology·Xiaoli YuYiting Liu
Jan 1, 1981·Annals of Neurology·A IqbalB G Arnason
May 1, 1982·Annals of Neurology·H L Weiner, S L Hauser
Jul 1, 2020·ACS Chemical Neuroscience·Giuseppe PezzottiOsam Mazda

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.